Precision Health Clinical Trials
Trifecta-Heart cfDNA-MMDx Study
Condition: Heart Transplant Rejection
Interventions: Diagnostic Test: MMDx diagnostic test; Diagnostic Test: Prospera; Diagnostic Test: HLA antibody
Sponsors: University of Alberta; Natera, Inc.; One Lambda
Recruiting
Interventions: Diagnostic Test: MMDx diagnostic test; Diagnostic Test: Prospera; Diagnostic Test: HLA antibody
Sponsors: University of Alberta; Natera, Inc.; One Lambda
Recruiting
For more information, visit the Study URL.
Whole-genome Sequencing Study in Patients With Diminished Ovarian Reserve
Condition: Diminished Ovarian Reserve
Intervention: Other: whole-genome sequencing
Sponsors: Nanfang Hospital of Southern Medical University; Ferring Pharmaceuticals
Recruiting
Intervention: Other: whole-genome sequencing
Sponsors: Nanfang Hospital of Southern Medical University; Ferring Pharmaceuticals
Recruiting
For more information, visit the Study URL.
LIQUIK: LIQUId Biopsy for Detection of Actionable Genomic BiomarKers in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
Condition: Non Small Cell Lung Cancer
Intervention:
Sponsor: Lucence Health Inc.
Recruiting
Intervention:
Sponsor: Lucence Health Inc.
Recruiting
For more information, visit the Study URL.
A Trial for Relapsed and Relapsed/Refractory Multiple Myeloma Patients
Conditions: Multiple Myeloma; Deletion 17P Syndrome
Interventions: Drug: Daratumumab; Drug: Pomalidomide; Drug: Dexamethasone
Sponsor: Fondazione EMN Italy Onlus
Recruiting
Interventions: Drug: Daratumumab; Drug: Pomalidomide; Drug: Dexamethasone
Sponsor: Fondazione EMN Italy Onlus
Recruiting
For more information, visit the Study URL.
Testing Tumor Tissue and Blood to Help Select Personalized Treatments for Patients With Suspected Lung Cancers
Condition: NSCLC
Intervention: Diagnostic Test: ctDNA, tumor NGS
Sponsors: Lung Cancer Mutation Consortium; Lung Cancer Research Foundation
Recruiting
Intervention: Diagnostic Test: ctDNA, tumor NGS
Sponsors: Lung Cancer Mutation Consortium; Lung Cancer Research Foundation
Recruiting
For more information, visit the Study URL.
A Pharmacodynamics-Driven Trial of Talazoparib, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Aberrations in Genes Involved in DNA Damage Response
Condition: Solid Tumors
Intervention: Drug: talazoparib
Sponsor: National Cancer Institute (NCI)
Not yet recruiting
Intervention: Drug: talazoparib
Sponsor: National Cancer Institute (NCI)
Not yet recruiting
For more information, visit the Study URL.
Genomic Study of Relapse Esophageal Cancer After Radiotherapy
Conditions: Gene Mutation-Related Cancer; Esophageal Cancer; Radiation Exposure
Intervention: Genetic: whole exome sequence
Sponsors: Fudan University; M.D. Anderson Cancer Center; Nantong University; Jiangsu Cancer Institute & Hospital; Henan Cancer Hospital; Ningbo No.2 Hospital; Taihe Hospital; Taian Cancer Hospital
Recruiting
Intervention: Genetic: whole exome sequence
Sponsors: Fudan University; M.D. Anderson Cancer Center; Nantong University; Jiangsu Cancer Institute & Hospital; Henan Cancer Hospital; Ningbo No.2 Hospital; Taihe Hospital; Taian Cancer Hospital
Recruiting
For more information, visit the Study URL.
Research of Pathological Imaging Diagnosis of Ocular Tumors Based on New Artificial Intelligence Algorithm
Conditions: Melanoma (Skin); Melanoma in Situ; Nevus Eye; Sebaceous Gland Carcinoma of the Eyelid; Basal Cell Carcinoma; Squamous Cell Carcinoma in Situ; Ocular Tumor
Intervention:
Sponsor: Peking University
Not yet recruiting
Intervention:
Sponsor: Peking University
Not yet recruiting
For more information, visit the Study URL.
Genetic Polymorphisms and Their Association With Temporomandibular Disorders
Conditions: Temporomandibular Disorders; Orofacial Pain
Interventions: Device: stabilization splint; Procedure: physical therapy; Device: placebo splint
Sponsor: Croatian Science Foundation
Recruiting
Interventions: Device: stabilization splint; Procedure: physical therapy; Device: placebo splint
Sponsor: Croatian Science Foundation
Recruiting
For more information, visit the Study URL.
AntiCMV molécules Monitoring in Real-life in Stem Cell Recipients
Conditions: Hematopoietic Stem Cell Transplantation; Cytomegalovirus Infections; Antivirals; Antiviral Drug Resistance
Intervention: Other: Real-life observatory of efficacy and resistance to anti CMV molecules in stem cell recipients
Sponsor: University Hospital, Limoges
Recruiting
Intervention: Other: Real-life observatory of efficacy and resistance to anti CMV molecules in stem cell recipients
Sponsor: University Hospital, Limoges
Recruiting
For more information, visit the Study URL.